Trulieve Cannabis Corp. (USD) Trulieve Cannabis Corporation, along with its various subsidiaries, functions as a prominent medical marijuana enterprise. This company manages the entire production cycle, from cultivating its own cannabis to manufacturing finished goods in-house. Its products are then distributed directly to consumers through Trulieve-branded dispensaries located in Florida, with the added convenience of home delivery services within the state. Trulieve boasts a wide array of cannabis product types, including traditional flower, edibles, vaporizer cartridges, concentrates, topical applications, capsules, tinctures, dissolvable powders, and even nasal sprays. These are offered under several proprietary brands, such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One. As of March 16, 2022, the company's retail presence included 162 dispensaries across multiple states. This network comprised 113 stores in Florida, 19 affiliated locations in Pennsylvania, 17 in Arizona, 5 in California, 3 in Maryland, 2 each in Massachusetts and West Virginia, and one in Connecticut. Beyond retail, Trulieve Cannabis Corp. also operates cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. Tracing its origins back to an incorporation in 1940, the company was initially known as Schyan Exploration Inc./Exploration Schyan Inc. It officially adopted the name Trulieve Cannabis Corp. in September 2018 and maintains its headquarters in Quincy, Florida.

Trulieve Cannabis Corp. (USD) Active

6749 Ben Bostic Road, Quincy, FL, US, 32351

Stock Price USD

Price Change

Last Dividend USD

TCNNF's stock peer is CHIZF (China Traditional Chinese Medicine Holdings Co. Limited)

TCNNF's stock peer is CMOPF (Cosmo Pharmaceuticals N.V.)

TCNNF's stock peer is GNTLF (Genetic Technologies Limited)

TCNNF's stock peer is KSPHF (Kissei Pharmaceutical Co., Ltd.)

TCNNF's stock peer is LJUIF (SSY Group Limited)

TCNNF's stock peer is NPNKF (Nippon Shinyaku Co., Ltd.)

TCNNF's stock peer is NPPNY (Nippon Shinyaku Co., Ltd.)

TCNNF's stock peer is SWGHF (Sawai Group Holdings Co., Ltd.)

TCNNF's stock peer is TWAPF (Towa Pharmaceutical Co., Ltd.)

Healthcare Drug Manufacturers - Specialty & Generic

Trulieve Cannabis Corporation, along with its various subsidiaries, functions as a prominent medical marijuana enterprise. This company manages the entire production cycle, from cultivating its own cannabis to manufacturing finished goods in-house. Its products are then distributed directly to consumers through Trulieve-branded dispensaries located in Florida, with the added convenience of home delivery services within the state. Trulieve boasts a wide array of cannabis product types, including traditional flower, edibles, vaporizer cartridges, concentrates, topical applications, capsules, tinctures, dissolvable powders, and even nasal sprays. These are offered under several proprietary brands, such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One. As of March 16, 2022, the company's retail presence included 162 dispensaries across multiple states. This network comprised 113 stores in Florida, 19 affiliated locations in Pennsylvania, 17 in Arizona, 5 in California, 3 in Maryland, 2 each in Massachusetts and West Virginia, and one in Connecticut. Beyond retail, Trulieve Cannabis Corp. also operates cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. Tracing its origins back to an incorporation in 1940, the company was initially known as Schyan Exploration Inc./Exploration Schyan Inc. It officially adopted the name Trulieve Cannabis Corp. in September 2018 and maintains its headquarters in Quincy, Florida.

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Recent News

Trulieve Announces Share Repurchase Program

TALLAHASSEE, Fla., June 9, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase up to the lesser of (i) $50 million in aggregate value, and (ii) 8,495,038 subordinate voting shares of the Company (being five percent (5%) of the Company's issued and outstanding subordinate voting shares as at June 8, 2026) over a 12-month period.

2026-06-09 08:00:00

Trulieve Announces Uplist to NYSE

Subordinate Voting Shares expected to begin trading under ticker "TRLV" on Wednesday, June 10 TALLAHASSEE, Fla., June 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its subordinate voting shares (the "Subordinate Voting Shares") have been approved for listing on the New York Stock Exchange ("NYSE").

2026-06-05 07:00:00

Trulieve Announces Proposed Domestication from British Columbia to Delaware

TALLAHASSEE, Fla., May 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that the Company will be seeking shareholder approval of a proposed plan of arrangement (the "Arrangement") which involves the continuance of the Company out from the province of British Columbia, Canada, and the concurrent domestication of the Company to the State of Delaware in the United States (the "Domestication").

2026-05-13 16:46:00

Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation

First quarter revenue of $287 million, with 59% gross margin Positive net income of $2 million and Adjusted EBITDA of $100 million* Rescheduling of medical marijuana to Schedule III enabled applications for DEA registration TALLAHASSEE, Fla., May 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended March 31, 2026.

2026-05-07 06:15:00

Trulieve to Open Medical Cannabis Dispensary in Belleview, Florida

New Marion County location will host grand opening celebration Friday, May 8 TALLAHASSEE, Fla., May 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Belleview, Florida.

2026-05-05 08:00:00

Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses

TALLAHASSEE, Fla., April 29, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state‑licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.

2026-04-29 15:43:00

Trulieve Applauds Trump Administration For Rescheduling Medical Marijuana to Schedule III

Reclassification Enables Research and Supports State Licensed Medical Marijuana Operators TALLAHASSEE, Fla., April 23, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., applauds the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.

2026-04-23 08:45:00

Trulieve Cannabis Corp. to Hold First Quarter 2026 Results Conference Call on May 7, 2026

TALLAHASSEE, Fla., April 17, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, May 7, 2026 at 8:30 AM Eastern Time following the release of its first quarter 2026 financial results.

2026-04-17 08:15:00

Trulieve to Open Medical Cannabis Dispensary in Tallahassee, Florida

New Leon County location will host grand opening celebration Monday, April 20 TALLAHASSEE, Fla., April 17, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Tallahassee, Florida.

2026-04-17 08:00:00

Trulieve to Open Medical Cannabis Dispensary in Boca Raton, Florida

New Glades Road location will host grand opening celebration Friday, April 24 TALLAHASSEE, Fla., April 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Boca Raton, Florida.

2026-04-13 08:00:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions